Login

Unlocking Nigerian Telecom Growth: Optiva's Role in Digital MVNO Success | Robert Stabile, CEO & Chairman of the Board at Optiva Inc 00:10:00

Share On Facebook Share On Twitter

Rob Stabile is Chairman/Interim CEO at Optiva Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Prince Hans Adam II on Transforming the State into a Service Company|Hans-Adam
00:10:00
Real estate firm adjusts dividend policy due to COVID-19, emphasizing rent and cashflow while anticipating trend acceleration |Richard Shepherd-Cross, Managing Director, Custodian Property Income REIT plc.
00:10:00
Empowering Employees and Solving Customer Pain Points - Interview Part 2 | Mr. Keoh Beng Huat, CEO, SFP Tech Holdings Berhad.
00:10:00
Allspring’s vision is to inspire a new era of investing that pursues both financial returns and positive outcomes. Diverse perspectives power our investment strategies through a unified platform and a commitment to our clients.| Joe Sullivan,Chief Executi
00:10:00
Peninsula Energy: Leading U.S. Uranium Producer with Strong Growth Potential
00:10:00
Seed specialists that partner with founders at the earliest stages to turn great ideas into category-defining companies|Mar Hershenson,Founding Managing Partner, Pear Ventures
00:10:00
Revisiting the Landscape: Macerich CEO Disputes Notion of A-Quality Regional Mall Decline
00:10:00
Jim Nesci on Blue Foundry Bank's Expansion and Competitive Edge | James D. Nesci, CEO, Blue Foundry Bank.
00:10:00
China as one of the first U.S. investors in the country's booming tech economy|Hans Tung,Investor, Notable Capital
00:10:00
Soluna Holdings, Inc. (SLNH) is the leading developer of green data centers converting excess renewable energy into computing power.
00:10:00
Strategies for Tax Efficiency: Minimizing Taxes in Your Investment Portfolio with J.P. Morgan Experts
00:10:00
Grindeks chairman of the board Juris Hmelnickis

© 2017 - Neuhu+